Literature DB >> 2284664

Tuberculosis in diabetic patients in Tanzania.

A B Swai1, D G McLarty, F Mugusi.   

Abstract

During a 1-7 year follow-up of 1250 African diabetic patients at Muhimbili Medical Centre, Dar es Salaam, 68 (5.4%) were known to have developed pulmonary tuberculosis and two (0.2%) spinal tuberculosis. In 18 (25.7%) of the 70 patients tuberculosis was diagnosed prior to the diagnosis of diabetes, and in 32 (45.7%) after the diagnosis of diabetes. In 20 (28.6%) patients tuberculosis and diabetes were diagnosed at approximately the same time with most presenting with symptoms of diabetes. The prevalence of tuberculosis was greater in the young, in those with a low body mass index (BMI), in patients with insulin-dependent diabetes mellitus compared to those with non-insulin-dependent diabetes mellitus (9.0% vs 2.7%) and in those whose diabetes was poorly controlled. Seventeen (24.3%) of the 70 patients are known to have died. Pulmonary tuberculosis may progress rapidly and a high index of suspicion is required. It remains a significant cause of morbidity and mortality among diabetic patients in developing countries.

Entities:  

Mesh:

Year:  1990        PMID: 2284664     DOI: 10.1177/004947559002000402

Source DB:  PubMed          Journal:  Trop Doct        ISSN: 0049-4755            Impact factor:   0.731


  19 in total

Review 1.  Tuberculosis and diabetes mellitus: convergence of two epidemics.

Authors:  Kelly E Dooley; Richard E Chaisson
Journal:  Lancet Infect Dis       Date:  2009-12       Impact factor: 25.071

2.  Important co-morbidity in patients with diabetes mellitus in three clinics in Western Kenya.

Authors:  N K Kirui; S D Pastakia; J H Kamano; S Cheng; E Manuthu; P Chege; A Gardner; A Mwangi; D A Enarson; A J Reid; E J Carter
Journal:  Public Health Action       Date:  2012-11-09

3.  'Cough-triggered' tuberculosis screening among adults with diabetes in Tanzania.

Authors:  G Mtwangambate; S E Kalluvya; B R Kidenya; R Kabangila; J A Downs; L R Smart; D W Fitzgerald; R N Peck
Journal:  Diabet Med       Date:  2013-11-18       Impact factor: 4.359

Review 4.  Tuberculosis Comorbidity with Communicable and Noncommunicable Diseases.

Authors:  Matthew Bates; Ben J Marais; Alimuddin Zumla
Journal:  Cold Spring Harb Perspect Med       Date:  2015-02-06       Impact factor: 6.915

5.  Glycated hemoglobin screening identifies patients admitted for retreatment of tuberculosis at risk for diabetes in Tanzania.

Authors:  Margaretha L Sariko; Stellah G Mpagama; Jean Gratz; Riziki Kisonga; Queen Saidi; Gibson S Kibiki; Scott K Heysell
Journal:  J Infect Dev Ctries       Date:  2016-04-28       Impact factor: 0.968

6.  Mycobacterial antigen-induced T helper type 1 (Th1) and Th2 reactivity of peripheral blood mononuclear cells from diabetic and non-diabetic tuberculosis patients and Mycobacterium bovis bacilli Calmette-Guérin (BCG)-vaccinated healthy subjects.

Authors:  R J Al-Attiyah; A S Mustafa
Journal:  Clin Exp Immunol       Date:  2009-10       Impact factor: 4.330

7.  Impact of diabetes mellitus on treatment outcomes of patients with active tuberculosis.

Authors:  Kelly E Dooley; Tania Tang; Jonathan E Golub; Susan E Dorman; Wendy Cronin
Journal:  Am J Trop Med Hyg       Date:  2009-04       Impact factor: 2.345

Review 8.  Special populations and pharmacogenetic issues in tuberculosis drug development and clinical research.

Authors:  Helen McIlleron; Susan Abdel-Rahman; Joel Alex Dave; Marc Blockman; Andrew Owen
Journal:  J Infect Dis       Date:  2015-06-15       Impact factor: 5.226

9.  Diabetes and tuberculosis: a review of the role of optimal glycemic control.

Authors:  Asfandyar Khan Niazi; Sanjay Kalra
Journal:  J Diabetes Metab Disord       Date:  2012-12-20

10.  Smear positive pulmonary tuberculosis among diabetic patients at the Dessie referral hospital, Northeast Ethiopia.

Authors:  Hiwot Amare; Aschalew Gelaw; Belay Anagaw; Baye Gelaw
Journal:  Infect Dis Poverty       Date:  2013-03-27       Impact factor: 4.520

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.